TRACT Therapeutics, Inc. — Form D

TRACT Therapeutics, Inc. of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2019-04-03. The offering totals $15.0M, of which $15.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2019-04-03
• Form: D
• Accession: 0001772729-19-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $15.0M
• Amount sold: $15.0M
• Investors: 1
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-336378

Issuer

• Name: TRACT Therapeutics, Inc.
• CIK: 0001772729
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 125 W. OAK STREET, SUITE D, CHICAGO, IL, 60610
• Phone: 312-324-8400

Officers, directors & promoters (10)

More

• CIK 1772729 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search